Clover Health Investments Corp - Ordinary Shares - Class A Stock News

Clover Health Investments, Corp. (CLOV) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Despite disappointing YTD earnings due to higher than expected medical costs, Clover's expected GAAP profitability in 2026 marks a critical inflection point. Clover's higher returning member mix and targeted growth measures aiming to bring more members under Clover Assistant quicker are major tailwinds to medical costs next year, in my opinion. Clover Assistant's early diagnosis capabilities se...

WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 Citi Global Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. Eastern Time.

Clover Health Investments, Corp. ( CLOV ) UBS Global Healthcare Conference 2025 November 11, 2025 11:00 AM EST Company Participants Peter Kuipers - Chief Financial Officer Presentation Unknown Analyst Okay. All right.

Clover Health Investments, Corp. ( CLOV ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Ryan Schmidt - Investor Relations Analyst Andrew Toy - Co-Founder, CEO & Director Peter Kuipers - Chief Financial Officer Conference Call Participants Jonathan Yong Presentation Operator Hello, and welcome to Clover Health's Third Quarter 2025 Earnings Call. [Operator Instructions] ...

Clover Health Investments (NASDAQ: CLOV) delivered its second consecutive profitable quarter tonight, beating earnings expectations and extending a streak of operational improvement that has quietly reshaped the Medicare Advantage insurer's narrative.

Business Highlights: Generates third quarter year-to-date positive Adjusted EBITDA profitability, on a wide network, while growing membership by 35% and revenue by 39% year-over-year, despite a greater proportion of new members relative to returning member base High coverage of Clover Assistant, including within new cohorts, will result in improved total cost of care Strong retention, above-mar...

WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-serving member of its Board of Directors, having joined the Board in early 2017, will conclude her service as of October 31, 2025.